In another active week for the IPO market, eight companies completed offerings, with the largest and most anticipated IPO, Wish (WISH), putting on an underwhelming performance. Surprisingly, this came alongside the best performing IPO of 2020...read more
908 Devices, which provides mass spectrometry devices for forensic and scientific research, raised $130 million by offering 6.5 million shares at $20, above the range of $18 to $19. The company had previously planned to offer 6.3 million shares at $15 to $17,...read more
908 Devices, which provides mass spectrometry devices for forensic and scientific research, raised the proposed deal size for its upcoming IPO on Thursday. The Boston, MA-based company now plans to raise $116 million by offering 6.3 million shares at a...read more
908 Devices, which provides mass spectrometry devices for forensic and scientific research, announced terms for its IPO on Monday.
The Boston, MA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the...read more
US IPO Weekly Recap: WISH not granted in week of otherwise stellar returns
In another active week for the IPO market, eight companies completed offerings, with the largest and most anticipated IPO, Wish (WISH), putting on an underwhelming performance. Surprisingly, this came alongside the best performing IPO of 2020...read more
908 Devices prices upsized IPO at $20, above the upwardly revised range
908 Devices, which provides mass spectrometry devices for forensic and scientific research, raised $130 million by offering 6.5 million shares at $20, above the range of $18 to $19. The company had previously planned to offer 6.3 million shares at $15 to $17,...read more
Research device developer 908 Devices raises range to $18 to $19 ahead of $116 million IPO
908 Devices, which provides mass spectrometry devices for forensic and scientific research, raised the proposed deal size for its upcoming IPO on Thursday. The Boston, MA-based company now plans to raise $116 million by offering 6.3 million shares at a...read more
Research device developer 908 Devices sets terms for $100 million IPO
908 Devices, which provides mass spectrometry devices for forensic and scientific research, announced terms for its IPO on Monday. The Boston, MA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the...read more